255 related articles for article (PubMed ID: 15251109)
1. After menopause: novel marker helps to identify women at risk for heart disease.
Lewis SL
J Fam Pract; 2004 Jul; Suppl():S18-24. PubMed ID: 15251109
[No Abstract] [Full Text] [Related]
2. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
[TBL] [Abstract][Full Text] [Related]
3. Raising awareness of women and heart disease--women's hearts are different.
Herrmann C
Crit Care Nurs Clin North Am; 2008 Sep; 20(3):251-63. PubMed ID: 18644507
[TBL] [Abstract][Full Text] [Related]
4. Guidelines update on the prevention of heart disease in women.
Caboral MF; King WV; Goolsby MJ
J Am Acad Nurse Pract; 2008 Apr; 20(4):191-3. PubMed ID: 18387015
[No Abstract] [Full Text] [Related]
5. Menopause. A flash of concern.
Wingert P
Newsweek; 2007 Apr; 149(16):16. PubMed ID: 17477154
[No Abstract] [Full Text] [Related]
6. Effect of HMR 3339, a novel selective estrogen receptor modulator, on C-reactive protein levels in healthy postmenopausal women.
Vogelvang TE; Mijatovic V; Kenemans P; Schalkwijk CG; van der Mooren MJ
Am J Cardiol; 2004 Nov; 94(9):1205-8. PubMed ID: 15518626
[TBL] [Abstract][Full Text] [Related]
7. Menopause: choices for women.
Kroon V; Boyd L
Aust Nurs J; 2001 Feb; 8(7):suppl 1-4. PubMed ID: 11894570
[No Abstract] [Full Text] [Related]
8. Women and heart disease.
Stuenkel CA
Med Sect Proc; 1994; ():203-15. PubMed ID: 7659713
[No Abstract] [Full Text] [Related]
9. Women and heart disease: what's new?
Cheek D; Sherrod M; Tester J
Nursing; 2007; 37 Suppl Cardiac():8-13. PubMed ID: 18046200
[TBL] [Abstract][Full Text] [Related]
10. Women & heart disease: What's new?
Cheek D; Sherrod M; Tester J
Nursing; 2008 Jan; 38(1):36-41; quiz 42. PubMed ID: 18160890
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence?
Salpeter S
Climacteric; 2005 Dec; 8(4):307-10. PubMed ID: 16390764
[TBL] [Abstract][Full Text] [Related]
12. Decisions on women's health: menopause and hormone replacement therapy.
Visser A
Patient Educ Couns; 2004 May; 53(2):119. PubMed ID: 15140449
[No Abstract] [Full Text] [Related]
13. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
de Maat MP; Madsen JS; Langdahl B; Bladbjerg EM; Tofteng CL; Abrahamsen B; Rejnmark L; Brixen K; Christensen K; Jespersen J; Kristensen SR
Thromb Haemost; 2007 Feb; 97(2):234-9. PubMed ID: 17264952
[TBL] [Abstract][Full Text] [Related]
14. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
15. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
Banks E; Canfell K
Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
[TBL] [Abstract][Full Text] [Related]
16. Health risks after cessation of postmenopausal hormone therapy.
Pines A; Sturdee D; Birkhäuser M;
Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
[No Abstract] [Full Text] [Related]
17. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
Barber CA; Margolis K; Luepker RV; Arnett DK
J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
[TBL] [Abstract][Full Text] [Related]
18. Hormone in the hot seat.
Mandavilli A
Nat Med; 2006 Jan; 12(1):8-9. PubMed ID: 16397539
[No Abstract] [Full Text] [Related]
19. Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause.
Birkhäuser MH; Panay N; Archer DF; Barlow D; Burger H; Gambacciani M; Goldstein S; Pinkerton JA; Sturdee DW
Climacteric; 2008 Apr; 11(2):108-23. PubMed ID: 18365854
[No Abstract] [Full Text] [Related]
20. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
Brinton RD
Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
